Biomarkers of Cardiometabolic Risk, Inflammation and Disease
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This book discusses recent advances in the area of cardiometabolic risk biomarkers of chronic inflammatory and cardiovascular disorders. Tackling the topic in a systematic manner, the book starts with an introduction to cardiometabolic risk and its clinical relevance, comparing emergent and classical biomarkers. It then goes on to discuss cardiometabolic risk biomarkers in a range of diseases, including diabetes, ischemic stroke and neurodegenerative disorders. Biomarkers of Cardiometabolic Risk, Inflammation and Disease is aimed at doctors specializing in internal medicine, neurology, cardiology, rheumatology, nephrology or endocrinology and will also be of interest to GPs, trainee doctors and clinical and basic researchers working on cardiovascular and autoimmune disorders. von Palavra, Filipe und Reis, Flávio und Marado, Daniela und Sena, Armando
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Filipe Palavra, MD Laboratory of Pharmacology and Experimental Therapeutics Institute for Biomedical Imaging and Life Sciences (IBILI) Faculty of Medicine, Coimbra University Coimbra, Portugal Flávio Reis, PhD Laboratory of Pharmacology and Experimental Therapeutics Institute for Biomedical Imaging and Life Sciences (IBILI) Faculty of Medicine, Coimbra University Coimbra, Portugal Daniela Marado, MD Department of Internal Medicine - B Centro Hospitalar e Universitário de Coimbra Coimbra, Portugal Armando Sena, MD, PhD Interdisciplinary Centre of Research Egas Moniz, CiiEM Caparica, Portugal
- paperback
- 430 Seiten
- Erschienen 2012
- Routledge
- paperback
- 508 Seiten
- Erschienen 2019
- Academic Press
- hardcover
- 553 Seiten
- Erschienen 2007
- Wiley-VCH
- hardcover
- 565 Seiten
- Erschienen 2003
- Humana
- perfect -
- Erschienen 1993
- Nürnberg : PERIMED-spitta, ...
- hardcover
- 464 Seiten
- Erschienen 2022
- Wiley-Blackwell
- paperback
- 293 Seiten
- Erschienen 1997
- Alternativemedicine.Com Books
- hardcover -
- Novartis Pharma
- hardcover
- 784 Seiten
- Erschienen 2016
- Academic Press
- Gebunden
- 476 Seiten
- Erschienen 2012
- Springer




